Welcome to GHM Genetic Development

We create new proprietary plant genetics by breeding strains that are rich in certain cannabinoids, which we then isolate and use in biomedical research to ultimately create health supplements and medication.

One of our major aims is to reduce the psychoactive properties and optimize the therapeutic potential of our extracts by
  • Cultivating varieties that are high in other cannabinoids than THC and producing new therapeutic cultivars by back crossing with existing strains
  • Shielding the psychoactive properties of THC by mixing with other non-psychoactive cannabinoids
  • Preventing the conversion of non-psychoactive THCA to THC by exploration of cold-extraction techniques

Our Goal

Our primary goal is to isolate plant-derived modulators of the endocannabinoid system (ECS) and refine them for biomedical research. Once we have identified the optimal formulation for any particular disease, we intend to breed new varieties, which confer these specific genetic traits.

details

Isolation & Research

GHM Genetic Development aims to isolate the active ingredients in medicinal plant extracts and tests their therapeutic potential both individually and in combination. We are international pioneers in breeding new plant varieties for therapeutic extracts.

details

Genetics

We have access to the world’s largest genetic library of therapeutic plant varieties. Our genetic library includes several unique landraces, which were obtained by the Strain Hunters on expeditions to the most remote regions of the world and will serve as a starting point for further genetic development.

details

Latest News

Driving Innovation Through Partnerships

Unique partnerships in Europe, Africa and North America, enable GHM Genetic Development to

  1. 1
    Follow Good Manufacturing Practice (GMP) Certified Production

    While our EU partners are certified, GHM will start the process of certification under the Good manufacturing practice (GMP). This helps to ensure that products are consistently produced according to the highest quality standards. GMP is designed to minimize the risks involved in the entire pharmaceutical production chain rather than simply testing the final product (WHO).

  2. 2
    Follow Good Agriculture Collection Practices (GACP)

    GHM Genetic Development and its partners follow the guidelines for good agricultural and collection practices (GACP) for medicinal plants developed by the WHO. This provides transparency and traceability in the cultivation and breeding process.

  3. 3
    Follow Good Distribution Practice (GDP) for Distribution

    Our partners practice Good Distribution Practice (GDP) according to the guidelines described by the WHO. These guidelines form the quality control system for the storage, sale and distribution of medicinal products for human use.

  4. 4
    Find Unique Phenotypes through Large Scale Outdoor Research Farm

    With our partner Green House DRC we have a government-licensed outdoor grow facility for the production of new plant genetics, raw plant material and crude plant extracts on an industrial scale.

  5. 5
    Test for Purity & Safety of all Products through Analytical Services

    Continuous quality control is crucial to the development and production of medicine and food supplements. We routinely check our crops, crude extracts and formulated products for their cannabinoid profiles and contaminants such as pesticides or microbes to ensure our products meet the highest quality standards.

WHAT DO WE DO?

GHM Genetic Development